Stay updated on LATITUDE Study: Daily Long-Acting Therapy Clinical Trial
Sign up to get notified when there's something new on the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page.

Latest updates to the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page
- Check4 days agoChange DetectedPublications updated: added Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges (NEJM 2026 Feb 26) and removed the earlier NEJM Online ahead of print entry (Feb 18, 2026).SummaryDifference0.0%

- Check11 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision: v3.4.3 is now listed, replacing v3.4.2.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a publication citation to the Publications section: Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges, N Engl J Med. 2026 Feb 18 (online ahead of print).SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.4.2 was added, and the government funding lapse notice was removed. These updates do not affect the study details, eligibility criteria, or locations.SummaryDifference0.3%

- Check54 days agoChange DetectedA government funding notice was added indicating possible processing delays and that the NIH Clinical Center is open. The site revision tag was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

Stay in the know with updates to LATITUDE Study: Daily Long-Acting Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page.